NEVOFARMA is a pharmaceutical access and distribution company committed to bridging global innovation with patients in need. By collaborating with international pharmaceutical manufacturers, biotech innovators and healthcare institutions, we support the introduction of advanced therapies—especially for rare and underserved conditions.
Our work is guided by scientific integrity, regulatory excellence, and a firm dedication to improving patient outcomes across diverse healthcare systems.
NevoFarma is a pharmaceutical company based in Türkiye, aiming to bring innovative and advanced treatment solutions to patients. The company focuses particularly on therapies addressing unmet medical needs.
NevoFarma provides solutions for innovative medicines, specialized treatments, and therapeutic areas with limited treatment options. Its focus includes critical, rare diseases and high-impact therapies.
NevoFarma’s mission is to transform scientific advancements into accessible treatments, improve patients’ quality of life, and create sustainable value within the healthcare sector.
Yes. NevoFarma establishes strategic partnerships with global pharmaceutical companies and healthcare stakeholders to ensure access to innovative treatments in Türkiye and surrounding region.
Yes. NevoFarma is headquartered in Istanbul and works closely with healthcare professionals across Türkiye and surrounding region.
NevoFarma provides healthcare professionals with most recent scientific information sharing, product training, and support programs that reflect current clinical approaches.
Our patient-centered approach refers to a healthcare philosophy that prioritizes human life, through enabling innovative treatments supported by strong science and timely access.
NevoFarma is positioned as an innovative pharmaceutical company, because it focuses on scientifically valuable, differentiated therapies that address critical medical needs rather than conventional approaches.